Team siliconindia

• Mahajan Imaging and Fortis La Femme form a strategic alliance to improve diagnostics for women and children.
• The partnership integrates advanced technology like AI, genomics, and imaging for early and accurate detection.
• The initiative aims to address critical gaps in preventive care, including low screening rates among Indian women.

In a major step to enhance healthcare for women and children in India, Mahajan Imaging & Labs and Fortis La Femme have announced a strategic alliance. The collaboration aims to provide advanced, accurate, and early diagnostic services by combining cutting edge technology with specialized clinical care.

Mahajan Imaging is a leader in high end diagnostics, known for bringing advanced technologies like Silent MRI, MR Mammography, Dual-Energy CT, and AI based pathology to India. With diagnostic centers across Delhi NCR and Jaipur, the organization is focused on delivering precision diagnostics that support early and effective treatment.

Fortis La Femme specializes in healthcare for women and children, offering services across maternity, IVF, neonatology, fetal medicine, and pediatric care. Their patient first approach is backed by specialized programs such as personalized maternity care and a human milk bank, setting them apart in women centric healthcare.

This partnership will offer integrated diagnostic solutions from imaging and genomics to pathology under one umbrella, helping clinicians make better decisions, faster. A key focus is improving access to preventive screening, especially as less than 1% of Indian women undergo cervical cancer screening, far below global health standards.

Also Read: Delhi Unveils India's First AI-Powered Ultra-Fast MRI at Mahajan Imaging Dwarka

By uniting technological innovation with clinical expertise, Mahajan Imaging and Fortis La Femme aim to bridge long standing gaps in diagnostic care and make world class healthcare more accessible to women and children across India.

This alliance marks a transformative moment in India’s healthcare landscape bringing together two powerhouses to set new benchmarks in quality, access, and early intervention.